Chemistry:YCT529
From HandWiki
Short description: Chemical compound
 | |
| Identifiers | |
|---|---|
| |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C29H25NO3 |
| Molar mass | 435.523 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
YCT529 is a drug which acts as a potent and selective antagonist of the Vitamin A receptor retinoic acid receptor alpha (RAR-α). In studies on mice it produced a 99% reduction in sperm production, and it has proceeded to early stage human clinical trials as a potential male contraceptive.[1]
The Vitamin A signalling system plays a number of important roles in bodily systems, such as the Immune system “It seems to me inherently unlikely that a compound with such activity would be free of side effects,” says Richard Sharpe, of the University of Edinburgh.[2]
See also
References
- ↑ "A non-hormonal pill could soon expand men's birth control options.". ACS News. 23 March 2022. https://www.acs.org/content/acs/en/pressroom/newsreleases/2022/march/non-hormonal-pill-could-soon-expand-mens-birth-control-options.html.
- ↑ "Male contraceptive pill is safe and effective in tests in mice.". New Scientist. 23 March 2022. https://www.newscientist.com/article/2313115-male-contraceptive-pill-is-safe-and-effective-in-tests-in-mice/.
 |  |
